Browsing by Author Tellis, C. C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 23  next >
TitleAuthor(s)Issue date
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changesApostolou, F.; Gazi, I. F.; Lagos, K.; Tellis, C. C.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M.24-Nov-2015
Association of Serum Paraoxonase-1 With Platelet Responsiveness to Clopidogrel in Patients With Acute Coronary SyndromesTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Ntalas, I. V.; Tellis, C. C.; Goudevenos, I. A.24-Nov-2015
The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatmentChristou, G. A.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015
Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-gamma activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase ARizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertensionChristogiannis, L. G.; Kostapanos, M. S.; Tellis, C. C.; Milionis, H. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015
THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2)Rizos, C. V.; Liberopoulos, E. N.; Tellis, C. C.; Florentin, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
The Effects of Hypolipidemic Treatment on Lipoprotein-Associated Phospholipase A2 in Patients with Mixed HyperlipidemiaAgouridis, A. P.; Kazakou, P. S.; Filippatos, T. D.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot StudyFlorentin, M.; Liberopoulos, E. N.; Tellis, C. C.; Derdemezis, C. S.; Elisaf, M.; Tselepis, A.24-Nov-2015
The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Dimitriou, A. A.; Tellis, C. C.; Elisaf, M. S.; Mikhailidis, D. P.; Tselepis, A. D.24-Nov-2015
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015
A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbitsRoussa, V. D.; Stathopoulou, E. M.; Papamichael, N. D.; Englezopoulos, C. V.; Rousouli, K. I.; Trypou, P.; Moussis, V.; Tellis, C. C.; Katsouras, C. S.; Tsikaris, V.; Tselepis, A. D.; Michalis, L. K.24-Nov-2015
A Highly Constrained Cyclic (S,S)-Cdc- Peptide Is A Potent Inhibitor Of Carotid Artery Thrombosis In RabbitsTsikaris, E.; Moussis, V.; Roussa, V. D.; Stathopoulou, E. M.; Papamichael, N. D.; Englezopoulos, C. V.; Trypou, P.; Tellis, C. C.; Katsouras, C. S.; Tselepis, A. D.; Michalis, L. K.24-Nov-2015
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Tellis, C. C.; Goudevenos, I. A.24-Nov-2015
Inhibitory Effects of Synthetic Peptide Analogues of the Human Platelet Integrin Alphaiibeta Subunit on Rabbit Platelet AggregationStathopoulou, E. M.; Roufou, C. E.; Koloka, V. N.; Tellis, C. C.; Sakarellos, C.; Sakarellos, M.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015
Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density LipoproteinGazi, I. F.; Apostolou, F.; Liberopoulos, E. N.; Filippatos, T. D.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Persistence of an atherogenic lipid profile after treatment of acute infection with brucellaApostolou, F.; Gazi, I. F.; Kostoula, A.; Tellis, C. C.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with beta-thalassemiaTselepis, A. D.; Hahalis, G.; Tellis, C. C.; Papavasiliou, E. C.; Mylona, P. T.; Kourakli, A.; Alexopoulos, D. C.24-Nov-2015
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015